AACR requests $7.6 billion for NCI

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The FY22 budget proposed by the White House doesn’t include sufficient funds to sustainably support NCI researchers, even though the proposal includes the largest ever funding increase for NIH, the American Association for Cancer Research said in a letter to House appropriators. 

“I feel very strongly that we need to do better. We need to have a payline and success rate that is comparable to the other NIH institutes and centers. For example, the 12.8 percent success rate at the NCI is occurring while the NIH-wide success rate for RPGs is nearly 21 percent, allowing the other NIH institutes and centers to fund approximately one out of five promising proposals, as opposed to NCI’s ability to fund one out of eight promising proposals,” David Tuveson, AACR president, said to The Cancer Letter. “We need the NIH to be strong—we need the NCI to be at least as strong as the other institutes in the NIH, because if it’s not, it will drag cancer research down, and it will ultimately impact and derail the whole point of the NIH.”

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Alexandria Carolan
Alexandria Carolan
Reporter

YOU MAY BE INTERESTED IN

Ivan Borrello, medical director of the Myeloma, Bone Marrow Transplant and Cell Therapies Program at Tampa General Hospital’s Cancer Institute, watched as flood waters from Hurricane Helene heaved against a contraption called the AquaFence, which is, as the name suggests, a water-impermeable barrier made of marine-grade laminate and various metals that can withstand storm surges of up to 15 feet above sea level. 
Alexandria Carolan
Alexandria Carolan
Reporter

Login